Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy.
Three hypogammaglobulinaemic patients with non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy were treated with lymphoblastoid alpha-interferon. All showed a striking improvement in serum aminotransferases after the start of each course of treatment.
D000361:Agammaglobulinemia / Q000628:therapy; D002908:Chronic Disease; D004340:Drug Contamination; D005440:Fluid Therapy; D006526:Hepatitis C / Q000628:therapy* / Q000635:transmission; D006525:Hepatitis, Viral, Human / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D010949:Plasma / Q000382:microbiology; D013163:Splenomegaly / Q000628:therapy; D013997:Time Factors; D000637:Transaminases / Q000097:blood; D005719:gamma-Globulins / Q000009:adverse effects*
D007370:Interferon Type I; D005719:gamma-Globulins; D000637:Transaminases